Join Scott Crae from Talking Medicines, Justin Wyman from Socialgist and Data Intelligence expert Roma English Owen in a fireside chat tackle one of today’s pressing questions: How can real-world conversational data shape more effective pharma marketing? By tapping into real-world audience insights on GLP-1 inhibitors and utilizing both open and closed community data from Socialgist, they demonstrated how AI can drive efficiency and effectiveness while boosting ROI through Curated Conversational Intelligence.
Discover what real-life Consumer conversations reveal about the evolving GLP-1 journey, from dose adjustments and weight loss plateaus to discontinuation, persistence, and the branded vs compounded debate.
Quickly solving a problem. Using real-life health related data to inform strategy. Shift from planning assumptions to real-life intelligence – powered by behavior, sentiment and engagement data.
Can large language models truly support regulatory-grade pharmaceutical communication? Learn more in our recent TMLabs briefing session.